"Designing Growth Strategies is in our DNA"

Myasthenia Gravis Treatment Market Size, Share & COVID-19 Impact Analysis, By Drug Class (Cholinesterase Inhibitors, Corticosteroids, Immunosuppressants, IVIg, and Monoclonal Antibodies); By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies), and Regional Forecast, 2021-2028

Region : Global | Format: PDF | Report ID: FBI106405

 

  1. Introduction
    1. Research Scope
    2. Market Segmentation
    3. Research Methodology
    4. Definitions and Assumptions
  2. Executive Summary
  3. Market Dynamics
    1. Market Drivers
    2. Market Restraints
    3. Market Opportunities
  4. Key Insights
    1. Recent Industry Developments – Mergers, Acquisitions & Partnerships
    2. New Product Launches, by Key Players
    3. Impact of COVID-19 on the Market
  5. Global Myasthenia Gravis Treatment Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. Corticosteroids
      3. Immunosuppressant
      4. IVIg
      5. Monoclonal Antibodies
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
    4. Market Analysis, Insights and Forecast – By Geography
      1. North America
      2. Europe
      3. Asia Pacific
      4. Rest of World
  6. North America Myasthenia Gravis Treatment Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. Corticosteroids
      3. Immunosuppressant
      4. IVIg
      5. Monoclonal Antibodies
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
    4. Market Analysis, Insights and Forecast – By Country
      1. U.S.
        1. By Drug Class
      2. Canada
        1. By Drug Class
  7. Europe Myasthenia Gravis Treatment Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. Corticosteroids
      3. Immunosuppressant
      4. IVIg
      5. Monoclonal Antibodies
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. U.K.
        1. By Drug Class
      2. Germany
        1. By Drug Class
      3. France
        1. By Drug Class
      4. Spain
        1. By Drug Class
      5. Italy
        1. By Drug Class
      6. Scandinavia
        1. By Drug Class
      7. Rest of Europe
        1. By Drug Class
  8. Asia Pacific Myasthenia Gravis Treatment Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. Corticosteroids
      3. Immunosuppressant
      4. IVIg
      5. Monoclonal Antibodies
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
    4. Market Analysis, Insights and Forecast – By Country/ Sub-region
      1. Japan
        1. By Drug Class
      2. China
        1. By Drug Class
      3. India
        1. By Drug Class
      4. Australia
        1. By Drug Class
      5. Southeast Asia
        1. By Drug Class
      6. Rest of Asia Pacific
        1. By Drug Class
  9. Rest of World Myasthenia Gravis Treatment Market Analysis, Insights and Forecast, 2017-2028
    1. Key Findings / Summary
    2. Market Analysis, Insights and Forecast – By Drug Class
      1. Cholinesterase Inhibitors
      2. Corticosteroids
      3. Immunosuppressant
      4. IVIg
      5. Monoclonal Antibodies
    3. Market Analysis, Insights and Forecast – By Distribution Channel
      1. Hospital Pharmacies
      2. Online Pharmacies
      3. Retail Pharmacies
  10. Competitive Analysis
    1. Global Market Share Analysis (2020)
    2. Company Profiles (Overview, Products, SWOT Analysis, Recent Developments, Strategies, Financials (Based on Availability))
      1. AstraZeneca
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      2. Astellas Pharma Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      3. F. Hoffmann-La Roche Ltd.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      4. Novartis AG
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      5. Veloxis Pharmaceuticals, Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      6. Bausch Health Companies Inc.
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
      7. Others
        1. Overview,
        2. Products,
        3. SWOT Analysis,
        4. Recent Developments,
        5. Strategies,
        6. Financials (Based on Availability)
Read Less

Figure 1:  Global Myasthenia Gravis Treatment Market Revenue Breakdown (USD billion, %) by Region, 2020 & 2028

Figure 2:  Global Myasthenia Gravis Treatment Market Value Share (%), by Drug Class, 2020 & 2028

Figure 3:  Global Myasthenia Gravis Treatment Market Value Share (%), by Distribution Channel, 2020 & 2028

Figure 4:  Global Myasthenia Gravis Treatment Market Value (USD billion), by Region, 2020 & 2028

Figure 5:  North America Myasthenia Gravis Treatment Market Value (USD billion), by Drug Class, 2020 & 2028

Figure 6:  North America Myasthenia Gravis Treatment Market Value Share (%), by Drug Class, 2020

Figure 7:  North America Myasthenia Gravis Treatment Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 8:  North America Myasthenia Gravis Treatment Market Value Share (%), by Distribution Channel, 2020

Figure 9:  North America Myasthenia Gravis Treatment Market Value (USD billion), By Country, 2020 & 2028

Figure 10:  North America Myasthenia Gravis Treatment Market Value Share (%), By Country, 2020

Figure 11:  Europe Myasthenia Gravis Treatment Market Value (USD billion), by Drug Class, 2020 & 2028

Figure 12:  Europe Myasthenia Gravis Treatment Market Value Share (%), by Drug Class, 2020

Figure 13:  Europe Myasthenia Gravis Treatment Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 14:  Europe Myasthenia Gravis Treatment Market Value Share (%), by Distribution Channel, 2020

Figure 15:  Europe Myasthenia Gravis Treatment Market Value (USD billion), By Country/ Sub-region, 2020 & 2028

Figure 16:  Europe Myasthenia Gravis Treatment Market Value Share (%), By Country/ Sub-region, 2020

Figure 17:  Asia Pacific Myasthenia Gravis Treatment Market Value (USD billion), by Drug Class, 2020 & 2028

Figure 18:  Asia Pacific Myasthenia Gravis Treatment Market Value Share (%), by Drug Class, 2020

Figure 19:  Asia Pacific Myasthenia Gravis Treatment Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 20:  Asia Pacific Myasthenia Gravis Treatment Market Value Share (%), by Distribution Channel, 2020

Figure 21:  Asia Pacific Myasthenia Gravis Treatment Market Value (USD billion), By Country/ Sub-region, 2020 & 2028

Figure 22:  Asia Pacific Myasthenia Gravis Treatment Market Value Share (%), By Country/ Sub-region, 2020

Figure 23:  Rest of World Myasthenia Gravis Treatment Market Value (USD billion), by Drug Class, 2020 & 2028

Figure 24:  Rest of World Myasthenia Gravis Treatment Market Value Share (%), by Drug Class, 2020

Figure 25:  Rest of World Myasthenia Gravis Treatment Market Value (USD billion), by Distribution Channel, 2020 & 2028

Figure 26:  Rest of World Myasthenia Gravis Treatment Market Value Share (%), by Distribution Channel, 2020

Figure 27:  Global Myasthenia Gravis Treatment Market Share (%), By Company, 2020

Table 1:  Global Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2028

Table 2:  Global Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 3:  Global Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Region, 2017-2028

Table 4:  North America Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2028

Table 5:  North America Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 6:  North America Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, By Country, 2017-2028

Table 7:  U.S. Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2028

Table 8:  Canada Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2028

Table 9:  Europe Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2028

Table 10:  Europe Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 11:  Europe Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2017-2028

Table 12:  Germany Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2028

Table 13:  U.K. Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2028

Table 14:  France Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2028

Table 15:  Italy Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2030

Table 16:  Spain Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2031

Table 17:  Scandinavia Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2032

Table 18:  Rest of Europe Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2033

Table 19:  Asia Pacific Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2028

Table 20:  Asia Pacific Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

Table 21:  Asia Pacific Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2017-2028

Table 22:  Japan Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2028

Table 23:  India Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2028

Table 24:  China Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2028

Table 25:  Australia Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2030

Table 26:  Southeast Asia Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2031

Table 27:  Rest of Asia Pacific Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2032

Table 28:  Rest of World Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Drug Class, 2017-2028

Table 29:  Rest of World Myasthenia Gravis Treatment Market Revenue (USD billion) Forecast, by Distribution Channel, 2017-2028

  • Feb, 2022
  • 2020
  • 2017-2019
  • 147

Healthcare Clients

3M
abbvie
Amgen
Ansell
Fresenius
Galemed
Grifols
Ipsos
iqvia
Johnson
Jubilant
Lek
Pfizer
Roche
Siemens Healthineers
Styker
uniliver

Client Testimonials

“This report is really well done and we really appreciate it! Again, I may have questions as we dig in deeper. Thanks again for some really good work.”

- U.S.-based biotechnology company focussing on treatment of chronic pain.

“Kudos to your team. Thank you very much for your support and agility to answer our questions.”

- Europe-based provider of solutions to automate data centre operations.

“We appreciate you and your team taking out time to share the report and data file with us, and we are grateful for the flexibility provided to modify the document as per request. This does help us in our business decision making. We would be pleased to work with you again, and hope to continue our business relationship long into the future.”

- India-based manufacturer of industrial and specialty intermediates with a strong global presence.

“I want to first congratulate you on the great work done on the Medical Platforms project. Thank you so much for all your efforts.”

- One of the largest cosmetics company in the world.

“Thank you very much. I really appreciate the work your team has done. I feel very comfortable recommending your services to some of the other startups that I’m working with, and will likely establish a good long partnership with you.”

- U.S. based startup operating in the cultivated meat market.

“We received the below report on the U.S. market from you. We were very satisfied with the report.”

- Global hearing aids manufacturer.

“I just finished my first pass-through of the report. Great work! Thank you!”

- U.S. based solar racking solutions provider.

“Thanks again for the great work on our last partnership. We are ramping up a new project to understand the imaging and imaging service and distribution market in the U.S.”

- World’s leading advisory firm.

“We feel positive about the results. Based on the presented results, we will do strategic review of this new information and might commission a detailed study on some of the modules included in the report after end of the year. Overall we are very satisfied and please pass on the praise to the team. Thank you for the co-operation!”

- Germany based machine construction company.

“Thank you very much for the very good report. I have another requirement on cutting tools, paper crafts and decorative items.”

- Japanese manufacturing company of stationery products.

“We are happy with the professionalism of your in-house research team as well as the quality of your research reports. Looking forward to work together on similar projects”

- One of the Leading Food Companies in Germany

“We appreciate the teamwork and efficiency for such an exhaustive and comprehensive report. The data offered to us was exactly what we were looking for. Thank you!”

- Intuitive Surgical

“I recommend Fortune Business Insights for their honesty and flexibility. Not only that they were very responsive and dealt with all my questions very quickly but they also responded honestly and flexibly to the detailed requests from us in preparing the research report. We value them as a research company worthy of building long-term relationships.”

- Major Food Company in Japan

“Well done Fortune Business Insights! The report covered all the points and was very detailed. Looking forward to work together in the future”

- Ziering Medical

“It has been a delightful experience working with you guys. Thank you Fortune Business Insights for your efforts and prompt response”

- Major Manufacturer of Precision Machine Parts in India

“I had a great experience working with Fortune Business Insights. The report was very accurate and as per my requirements. Very satisfied with the overall report as it has helped me to build strategies for my business”

- Hewlett-Packard

“This is regarding the recent report I bought from Fortune Business insights. Remarkable job and great efforts by your research team. I would also like to thank the back end team for offering a continuous support and stitching together a report that is so comprehensive and exhaustive”

- Global Management Consulting Firm

“Please pass on our sincere thanks to the whole team at Fortune Business Insights. This is a very good piece of work and will be very helpful to us going forward. We know where we will be getting business intelligence from in the future.”

- UK-based Start-up in the Medical Devices Sector

“Thank you for sending the market report and data. It looks quite comprehensive and the data is exactly what I was looking for. I appreciate the timeliness and responsiveness of you and your team.”

- One of the Largest Companies in the Defence Industry
We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies . Privacy.
X